With its 26,000 enrolled students, the University of Zurich (UZH) is Switzerland’s largest university. Founded in the year 1833, UZH was Europe’s first university to be established by a democratic political system; today, UZH is one of the foremost universities in the German-speaking world. Made up of seven faculties covering some 100 different subject areas, the University offers a wide variety of Bachelor’s, Master’s and PhD programs. In addition, UZH’s continuing education programs offer excellent learning opportunities.
As a member of the “League of European Research Universities” (LERU), the University of Zurich belongs to Europe’s most prestigious research institutions. Numerous distinctions highlight the University’s international renown in the fields of medicine, immunology, genetics, neuroscience and structural biology as well as in economics. To date, the Nobel Prize has been conferred on twelve UZH scholars.
The academic excellence of the University of Zurich brings benefits to both the public and the private sectors not only in the Canton of Zurich, but throughout Switzerland. Knowledge is shared in a variety of ways: in addition to granting the general public access to its twelve museums and many of its libraries, the University makes findings from cutting-edge research available to the public in accessible and engaging lecture series and panel discussions.
Follow UZH on Facebook and Twitter:
Dr. Michael Otmar Hengartner
Michael Hengartner is the 83rd president of the University of Zurich (UZH). The Swiss-Canadian citizen, born in St.Gallen, Switzerland, grew up in Québec City, Canada, and studied biochemistry at the Université Laval. After his PhD studies at the Massachusetts Institute of Technology with Nobel laureate H. Robert Horvitz, he led for seven years a research group at the Cold Spring Harbor Laboratory in the USA. In 2001, he became the first occupant of the Ernst Hadorn Endowed Chair for molecular biology at the Institute of Molecular Life Sciences at UZH. From 2009 to 2014, he was dean of the Faculty of Science. Michael holds an Executive MBA from IMD, Lausanne and is the recipient of several awards for his research on the molecular basis of apoptosis, among them the Swiss National Latsis Prize and an honorary doctorate from the Université Pierre et Marie Curie. In 2010, Michael received the Credit Suisse Award for Best Teaching at UZH.